Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” fourth quarter 2024 ...

He also has untreated sleep apnea. He would like to try one of the GLP-1 drugs to lose some weight, but I am concerned about ...

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

The use of GLP-1 receptor agonists, like semaglutide, to treat type 2 diabetes is not associated with an increased risk of ...

Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of ...

My 66-year-old husband recently received a diagnosis of heart failure with preserved ejection fraction. He is 5 feet, 7 inches tall, and weighs 270 pounds. He is treating his fluid retention with 100 ...

There is initial evidence that low-dose semaglutide may reduce craving and drinking outcomes in individuals with alcohol-use disorder.

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...